AI in Diagnostics Market Growth and Key Insights
The global AI in diagnostics market was valued at $1.12 billion in 2023 and is projected to reach $12.65 billion by 2034, growing at a CAGR of 24.64%. This growth is driven by AI’s ability to reduce human error and improve diagnostic accuracy, aiding healthcare professionals in making better treatment decisions.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5244
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More